Deep divefrom Episode 8Fat loss4 November 202621 min

The Mouse That Pees Out Its Calories, and Its Kidneys Pay

A deep dive into one paper: what was known before, what the researchers did, what the numbers say and what they don't.

The paper: Renal nutrient loss promotes metabolic health at the expense of increased vulnerability to acute kidney injury (bioRxiv preprint)

MP3

Chapters

Transcript

The script the two AI voices read from. The times are worked out from the script, not heard, so a line can start a few seconds early or late.

Read the whole episode

Cold open

Host 1You heard the trailer — this is the whole story. Welcome to the Hastrup Review of Science — where artificial intelligence reads real science, so you don't have to pretend you understood the paper. Today, one mouse strain that eats more, stays lean, and pays for it with its kidneys.

Host 2The paper is by Harry Cutler, David James and colleagues at the University of Sydney, with metabolomics from Keio University in Japan and lipidomics from the National University of Singapore. It is a bioRxiv preprint posted on the twenty-ninth of September, so it has not been peer reviewed yet. We read the full text, and every number today comes from it.

Host 1And the one-sentence version?

Host 2Out of eleven inbred mouse strains fed a junk-food diet, one called BXD thirty-four ate more calories than the standard lab mouse but barely gained fat, apparently because its kidneys let a wide range of nutrients escape into the urine. The same mice then turned out to be extremely fragile when their kidneys were deliberately injured.

Why this field exists

Host 1Let's start further back. Why is energy balance a field at all?

Host 2As background: the textbook equation for body weight is energy in minus energy out. If you eat more than you burn, the surplus gets stored, mostly as fat. Most obesity research for the last century has been about one side or the other of that equation, appetite or expenditure.

Host 1But people clearly don't all respond the same way to the same surplus.

Host 2No, and the paper opens with exactly that. It cites the classic overfeeding studies, the best known being Claude Bouchard's identical twin experiment published in nineteen ninety, where weight gain under a controlled surplus varied several-fold between individuals. And it notes that how badly people's metabolism suffers from the same weight gain also differs between populations.

Host 1So something else is deciding where the excess goes.

Host 2That's the framing. The authors point out that there is a third term in the equation people tend to forget: energy-containing molecules can simply leave the body. And the kidney is the organ that decides, molecule by molecule, whether something filtered out of the blood gets taken back or gets flushed.

What was known before

Host 1Give me the kidney basics.

Host 2As background: the kidneys filter something like one hundred and eighty litres of plasma a day. That filtrate contains glucose, amino acids, small organic acids, all things the body wants back. Almost all of it is pulled back in the proximal tubule, the first stretch of the kidney's plumbing, by transporter proteins sitting in the cell membrane.

Host 1And that's where SGLT two comes in.

Host 2Right. SGLT two is the main transporter that reclaims filtered glucose, and SGLT two inhibitor drugs, such as empagliflozin and dapagliflozin, deliberately block it so glucose spills into the urine. The paper notes they've been used for type two diabetes for more than a decade, and that they show changing what the kidney reabsorbs can improve whole-body metabolism.

Host 1Do people lose a lot of weight on them?

Host 2The paper says the weight loss is typically modest. As background, the usual explanation is that people partly compensate by eating a bit more. There's also a human genetic version, familial renal glucosuria, caused by loss-of-function variants in the gene for SGLT two, where people can lose up to one hundred and sixty grams of glucose a day in urine in severe cases.

Host 1And those people are fine?

Host 2According to the studies the paper cites, the condition has been associated with lower obesity risk, and it is not typically associated with kidney tubule injury. Hold onto that, because it matters later.

The open question

Host 1So what's the gap this paper is aiming at?

Host 2We know a drug can make the kidney waste nutrients on purpose. What nobody had shown is whether natural, inherited differences in how tightly the kidney holds on to nutrients help explain why some individuals get metabolically sick on a bad diet and others don't.

Host 1And you don't find that by studying one lab mouse.

Host 2Exactly. Most metabolism research uses a single strain, C fifty-seven B L six J, which is one genetic individual copied many times. If you want natural variation, you have to bring in genetically different strains and see who responds differently.

What this paper did

Host 1Walk me through what they actually did.

Host 2Step one was a screen. Eleven inbred strains, male mice enrolled at twelve to fourteen weeks old, fed either normal chow or a high-fat high-sugar diet for six weeks. The junk diet got forty-five percent of its calories from fat, including twenty-two percent lard by weight and about twenty percent sucrose.

Host 1What's BXD thirty-four, by the way?

Host 2As background, the BXD strains are recombinant inbred lines bred from a cross between the standard C fifty-seven B L six mouse and another classic strain, DBA two. Each BXD line carries its own shuffled mix of the two parental genomes, which makes them a standard tool for finding genetic effects.

Host 1What did they measure in the screen?

Host 2Body fat by a small MRI-style scanner, an oral glucose tolerance test, insulin before and fifteen minutes after the glucose dose, and a set of blood markers like triglycerides and liver enzymes. Then for the standout strain they went deeper with something called the Dual Tracer Test.

Host 1Which is?

Host 2It's a method this same group published in twenty twenty-three. Under anaesthesia, the mouse gets one radioactive version of a glucose analogue, then forty minutes later a second, differently labelled version together with insulin. Because the two labels can be told apart, you get baseline and insulin-stimulated glucose uptake in each tissue of the same animal.

Host 1Then the energy budget.

Host 2A separate cohort, five weeks on the diets, then metabolic cages. After five days of getting used to them, the cages recorded oxygen and carbon dioxide every twenty minutes for forty-eight hours, plus food and water intake. Energy balance was calories eaten minus calories burned.

Host 1And the molecular side?

Host 2Urine metabolomics by capillary electrophoresis mass spectrometry at Keio, lipid profiling of liver and thigh muscle, and quantitative proteomics across six tissues. They also took single muscle fibres out of the mice and bathed them in palmitate, a saturated fat, to test whether the muscle itself resists fat-induced insulin resistance.

Host 1Any human data?

Host 2Two indirect links. One is a Spanish urine metabolomics cohort called OSARTEN, with fifty-one urinary metabolites measured in nine thousand two hundred and four people. The other is a tool called Synteny, also from this group, which asks whether a list of genes is enriched for genetic associations with particular human traits.

Host 1And then the kidney stress test.

Host 2Yes. They took bulk kidney proteomics and compared it against a large single-cell atlas of mouse diabetic kidney disease, to infer which kidney cell types were present and how disease-like they looked. Then, after eight weeks on the diets, they gave mice a single injection of folic acid at high dose, which is an established way to injure kidney tubules.

Results

Host 1Results. Start with the screen.

Host 2Every strain got fatter on the junk diet, but glucose tolerance only worsened in five of the eleven. The two most obesity-resistant strains were BXD thirty-four and a wild-derived strain called CAST, which gained only three and seven percent adiposity respectively.

Host 1Why did BXD thirty-four win over CAST?

Host 2Both kept normal glucose tolerance, but in CAST the junk diet pushed insulin levels up after glucose, which hints the pancreas was working harder to compensate. BXD thirty-four showed no such rise, so the authors called it the most broadly protected strain.

Host 1And the tracer test?

Host 2In standard C fifty-seven B L six mice, the diet made both muscles they measured and both fat depots insulin resistant. BXD thirty-four on the same diet kept normal insulin-stimulated glucose uptake in both muscles and in the fat under the skin. The abdominal fat depot did lose some insulin response in BXD thirty-four, but less than in the standard mice.

Host 1Now the energy budget, which I gather is the strange part.

Host 2It is. In the metabolic cage cohort, the resistance to fat gain replicated. On the junk diet BXD thirty-four ate more calories and had a positive energy balance, just like the standard mice, yet their fat percentage did not change.

Host 1So they were burning it off?

Host 2No. Energy expenditure didn't explain it, and neither did the respiratory exchange ratio, which tells you whether the body is burning mostly fat or carbohydrate. What did stand out was water: BXD thirty-four drank about one point seven times as much as the standard mice.

Host 1A mouse that drinks a lot and stays thin.

Host 2And across the mice in those cages, water intake and body mass were strongly negatively correlated, with a correlation coefficient of minus zero point eight six. That's what sent them to look at urine.

Host 1What was in the urine?

Host 2More than seventy percent of the variation in the urine metabolome came down to strain, against about eighteen percent for diet. Of one hundred and thirty-nine metabolites that differed by strain, one hundred and twenty-six were higher in BXD thirty-four.

Host 1Any single standout?

Host 2Glutarate, a small dicarboxylic acid, was about one hundred and twenty times higher in BXD thirty-four urine on chow and about three hundred and fifty times higher on the junk diet. One honest note: that urine analysis rests on four mice per strain per diet.

Host 1So were their tissues protected from the fat?

Host 2Lipid profiling of liver and muscle, five mice per group, showed near-complete protection of BXD thirty-four from the fat build-up the diet caused in standard mice. That's ectopic fat, fat stored in organs that shouldn't hold much of it, and it's closely tied to insulin resistance.

Host 1Maybe BXD thirty-four muscle is just tougher.

Host 2That's exactly what the palmitate experiment tested. Isolated muscle fibres from both strains were exposed to one hundred and fifty micromolar palmitate, and in both strains it impaired the insulin-driven movement of the glucose transporter GLUT four to the cell surface to a similar degree.

Host 1So the muscle isn't special. It just never sees the fat.

Host 2That's the authors' interpretation: the protection comes from reduced nutrient exposure, not from intrinsically resistant tissue. The proteomics backs that up, because muscle and abdominal fat proteins barely differed between strains, while the kidney was the most different organ of the six.

Host 1What was different in the kidney?

Host 2The biggest theme was transport across membranes. Of sixty-seven transport proteins that differed between strains, fifty-seven were lower in BXD thirty-four, and that pattern was specific to the kidney, with fewer than five such proteins changing in any other tissue.

Host 1Including SGLT two?

Host 2Including SGLT two, roughly halved in BXD thirty-four kidneys. But it's much broader than one drug target: about eighty percent of the reduced solute carriers sit in the cell membrane, and their known cargo spans amino acids, sugars, carboxylic acids, lipids and nucleosides.

Host 1So it's like a natural, very broad SGLT two inhibitor.

Host 2That's a fair picture, with the caveat that it's an inferred mechanism from protein levels, not a measured reabsorption rate. The kidney's own metabolism was also rewired, toward burning fat, with more fatty acid oxidation and TCA cycle proteins, less of several glycolysis enzymes, and more glutathione machinery, which the authors read as a sign of increased oxidative stress.

Host 1Anything odd in there?

Host 2Two things. Despite leaking almost everything else, BXD thirty-four kept carnitine, the molecule that ferries fats into mitochondria, and urine carnitine was substantially lower. And two enzymes, D two H G D H and ADHFE one, were strongly increased, pointing to more cycling of a molecule called D-two-hydroxyglutarate, which is known to be toxic to cells and is elevated in kidney disease.

Host 1And did they measure that molecule directly?

Host 2Not cleanly. Their method couldn't separate two-hydroxyglutarate from a similar compound, citramalate, though the combined signal was clearly higher in BXD thirty-four. The authors say outright that neither increased flux nor a causal role for this molecule is established by their data.

Host 1And the human links you mentioned?

Host 2In the OSARTEN cohort, after adjusting for age and sex, nine urinary metabolites were associated with fasting blood glucose. Projected onto the mouse urine, BXD thirty-four scored on the low-glucose side of that signature.

Host 1And the genetics?

Host 2Human versions of the genes for the altered transporters were enriched for genetic associations with H b A one c, the long-term blood sugar marker, spread across several genes rather than one. The figure legend notes those markers are nominal significance, so this is suggestive rather than nailed down.

A word from our sponsor

Host 1Before we get to the kidney injury, a short break.

Host 1Is your skin barrier leaking solutes? Have your transporters been quietly downregulated?

Host 2The Hastrup Review of Science is brought to you by beard oil. A small glass bottle of plant oils, applied to the chin, and reabsorbed at a rate no one has ever measured.

Host 1I don't have a beard. I applied it anyway, and it was retained in full.

Host 2Beard oil is sold online and in shops at ordinary prices. No metabolic cage, no folic acid, no proteomics. The link is in the show notes.

The kidney cost

Host 1Back to the kidneys. Did they look damaged before anyone injured them?

Host 2Using the single-cell atlas to deconvolve the bulk proteomics, BXD thirty-four kidneys had a higher inferred share of injured proximal tubule cells even on normal chow. The authors call that a pre-existing, injury-associated tubular state.

Host 1And the junk diet made it worse?

Host 2It changed the inferred cell makeup only modestly, but it shifted function. Injured tubule cells looked more like diabetic kidney disease in both strains, and the blood vessel lining cells responded in opposite directions.

Host 1Opposite how?

Host 2In the standard mice, the junk diet raised three endothelial proteins linked to vascular protection and recovery after kidney injury: ENTPD one, THBD and ESAM. In BXD thirty-four that response was absent, and ENTPD one actually went down. The authors read that as a protective adaptation the standard mouse mounts and BXD thirty-four doesn't.

Host 1Then the actual test.

Host 2After eight weeks on the diets, every mouse got a single fixed dose of seven point five milligrams of folic acid by injection, equivalent to the standard two hundred and fifty milligrams per kilo for a thirty-gram mouse. All groups lost weight and showed kidney injury.

Host 1And survival?

Host 2The folic acid killed every one of the junk-diet BXD thirty-four mice, one hundred percent, with none surviving to day seven. In junk-diet standard mice it killed twelve percent, a difference from chow that wasn't statistically significant, and no chow-fed mouse of either strain died.

Host 1So BXD thirty-four on chow survived fine.

Host 2Yes, which is important. The fragility only became lethal when the kidney had both the BXD thirty-four background and the diet stress. And the standard mice were not unscathed: tissue sections and blood urea nitrogen showed more severe injury in the junk-diet standard mice, consistent with earlier reports that a high-fat diet worsens this kind of injury.

Why it matters

Host 1So what's the principle here?

Host 2That the energy balance equation has a third term worth taking seriously. How much of what you eat your body actually keeps depends partly on what the kidney lets go, and in this mouse that was enough to roughly cancel out a dietary surplus.

Host 1And the trade-off part?

Host 2The authors call it a renometabolic trade-off. Genetic variation didn't make this mouse healthier overall, it moved the risk from fat, liver and muscle onto the kidney. Their broader point is that genetic diversity can reveal states that redistribute disease risk between organs rather than simply removing it.

Host 1Who should care?

Host 2Mainly people working on obesity drugs and kidney physiology. The question the authors pose is not whether to make the kidney leak more, but whether the metabolic benefit of nutrient loss can be separated from whatever made these kidneys fragile.

Host 1Do they think it can be?

Host 2They think it might, and that's where the human glucosuria families come back in. Those people lose large amounts of glucose without typical tubule injury, so the authors argue the damage in BXD thirty-four comes from the broader package of adaptations, not from nutrient wasting as such.

Host 1What does this not mean?

Host 2It does not mean SGLT two inhibitors damage kidneys; as background, large clinical trials have found they protect kidney function in many patients, and this paper doesn't test any drug. It doesn't mean drinking more water makes you thinner; the water intake here looks like a consequence of losing solutes, not a cause. And it doesn't show that any human carries a BXD thirty-four-like kidney.

Caveats

Host 1Then the caveats, all of them.

Host 2First, this is one mouse strain, all male, compared mostly against one reference strain. Second, it's a preprint, so nothing here has been through peer review.

Host 1What about the central claim, that nutrients leaving in urine explain the missing calories?

Host 2That is still an inference. The urine data are concentrations from small spot samples in four mice per group, not a full twenty-four-hour collection converted into calories, so we can't check that the urinary loss adds up to the energy gap. And as far as we could see, the paper doesn't report energy lost in faeces, which is another route out of the body.

Host 1And causation?

Host 2Nobody switched the transporters off or on to show they cause the protection or the fragility. The kidney findings are protein levels and computational deconvolution against a reference atlas, which tells you what the kidney resembles, not what it's doing. The authors themselves say the vulnerability probably reflects several things combined rather than one lesion.

Host 1Anything about the folic acid experiment?

Host 2It's a single type of injury, and the fixed seven point five milligram dose means a lighter mouse received more per kilo, which the paper chose deliberately to avoid giving obese mice a bigger dose. Also, the twelve percent versus one hundred percent comparison is striking, but the body-weight data use sixteen mice per group, and the survival analysis group sizes aren't spelled out in the text we read.

Host 1And the human side?

Host 2Both human links are indirect. Many of the metabolites most raised in BXD thirty-four, including glutarate, weren't measured in the human cohort, and the genetic enrichment is nominal. They support plausibility, not a human mechanism.

What to watch next

Host 1What should we watch for next?

Host 2The obvious one is finding the gene or genes in BXD thirty-four responsible, which the BXD family is designed to allow. Then a direct calorie balance with urine and faeces measured, and experiments that switch individual pieces of the programme on or off to see which part buys the metabolic protection and which part costs the kidney.

Host 1And in people?

Host 2Whether natural variation in human renal nutrient handling tracks obesity resistance and kidney injury risk together, for example in people who stay lean despite eating a lot, or in hospital acute kidney injury cohorts. That would tell us whether this trade-off is a mouse curiosity or a general rule.

Bottom line

Host 1Bottom line?

Host 2One mouse strain resists junk-food obesity and insulin resistance while eating more, and the best explanation on offer is that its kidneys let a broad range of nutrients go. The same kidneys look subtly injured at baseline and failed completely under a combined diet and toxic challenge. It's a well-built single-strain story, with the mechanism still inferred rather than proven.

Sign-off

Host 1That is the deep dive: Renal nutrient loss promotes metabolic health at the expense of increased vulnerability to acute kidney injury, by Harry Cutler, David James and colleagues, a preprint on bioRxiv. The link is in the show notes.

Host 1Every Friday this same feed carries the roundup episode: five new papers as trailers, and you pick which become deep dives. This has been the Hastrup Review of Science.